Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection

Globally, chronic hepatitis B (CHB) infection is one of the leading causes of liver failure, decompensated cirrhosis, and hepatocellular carcinoma. Existing antiviral therapy can suppress viral replication but not fully eradicate the virus nor the risk of liver-related complications. Novel treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Mak, Lung-Yi, Seto, Wai-Kay, Yuen, Man-Fung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235765/
https://www.ncbi.nlm.nih.gov/pubmed/34207458
http://dx.doi.org/10.3390/v13061169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235765/
https://www.ncbi.nlm.nih.gov/pubmed/34207458
http://dx.doi.org/10.3390/v13061169

Ejemplares similares